Amyloidosis

BridgeBio Pharma, Amyloidosis, Clinical trial results, Acoramidis, European Society of Cardiology, Transthyretin amyloid cardiomyopathy

BridgeBio Exposes Phase 3 Acoramidis Insights, Mortality Figures

Anika Sharma

In the intricate dance of scientific exploration, BridgeBio has taken a resolute plunge into the depths of phase 3 acoramidis ...